Mirum Pharmaceuticals Inc (MIRM)

Operating Cash Flow (Statement)

-$456.03M

TTM · Period ending: · USD

MIRM logo

MIRM Operating Cash Flow (Statement)

Latest reported-$456.03M
MIRM TTM Cash from Operations (-$39.36M → -$456.03M)
High-resolution chart · PNG

MIRM operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Mirum Pharmaceuticals Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-456,030,000
-170,975,000
55,827,000
44,692,000
8,995,000
-6,848,000
10,325,000
-1,225,000
-23,430,000
-36,958,000
-70,944,000
-88,596,000
-96,400,000
-99,241,000
-120,136,000
-119,013,000
-127,190,000
-147,217,000
-132,758,000
-135,890,000
-119,139,000
-95,934,000
-89,075,000
-66,494,000
-64,264,000
-55,287,000
-39,362,000
-26,204,500
-10,983,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.